biopharmaceutical company, acquired by AstraZeneca in 2007
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
AstraZeneca’s add-on treatment for rare blood disease gets USFDA nod: In 2021, AstraZeneca gained the drug in its acquisition of Alexion for $39 billion. In 2019 ...
financialexpress.com/healthcare/pharma-healthcare/astrazenecas-add-on-treatment-for-rare-blood-disease-gets-usfda-nod/3444136/
AstraZeneca will cap inhaler costs at $35 per month: The cost-reduction strategy follows a similar move from Boehringer Ingelheim, a rival in the medical device ...
washingtonpost.com/business/2024/03/18/astrazeneca-inhaler-price-cap/
Quick Glance: AstraZeneca caps out-of-pocket costs for inhalers
- AstraZeneca announced it will cap out-of-pocket costs for inhaled respiratory products in the US at $35 per month, following a similar move by rival Boehringer Ingelheim.
- This decision comes amidst increasing political scrutiny of high drug prices in the US, particularly for inhalers used to treat asthma and chronic obstructive pulmonary disease.
- The out-of-pocket cost cap will be effective from June 1 for AstraZeneca's entire respiratory product portfolio, including popular inhalers like Airsupra, Bevespi Aerosphere, and Breztri Aerosphere.
- AstraZeneca CEO Pascal Soriot emphasized the need for comprehensive healthcare reform to ensure patients can afford essential medications.
GSK to cap out-of-pocket inhaler costs in US: British pharmaceutical giant GSK said on Wednesday it would cap out-of-pocket costs for all its inhaled asthma and ...
reuters.com/business/healthcare-pharmaceuticals/gsk-cap-out-of-pocket-inhaler-costs-us-2024-03-20/
Federal Judge Dismisses Pharma Giant's Challenge to Medicare Drug Price Negotiations
commondreams.org/news/astrazeneca-drug-prices
Medicare is covering Wegovy, a new $4 million drug, and AstraZeneca bets $2 billion: pharma news round up
qz.com/wegovy-medicare-astrazeneca-orchard-therapeutics-1851360075
Paid articlePaid
How to recognize WHF in patients with HFrEF and improve outcomes? 🖥️ Join as experts discuss GDMT and additional therapy to tackle these clinical issues ... Show more ms.spr.ly/6182iL0pE
Mixed Outcomes in European Markets; U.S. Approval Elevates AstraZeneca: On February 19, European stock markets displayed mixed outcomes, halting a three-day gain ...
riotimesonline.com/mixed-outcomes-in-european-markets-u-s-approval-elevates-astrazeneca/
Facing the Challenges: Expert Perspectives on Managing Worsening Heart Failure: How to recognize WHF in patients with HFrEF and improve outcomes? Join as experts ...
ms.spr.ly/6182iL0HK
On This Day, Jan. 4: Nancy Pelosi is 1st woman elected speaker of the House - UPI.com
upi.com/Top_News/2023/01/04/On-This-Day-Pelosi-is-1st-woman-elected-speaker-of-the-House/6371672800417/
AstraZeneca, Sanofi RSV infant shots approved in China: AstraZeneca (AZN.L) said on Tuesday that its respiratory syncytial virus (RSV) immunization for infants ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-sanofis-rsv-infant-shots-approved-china-2024-01-02/
AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal: AstraZeneca (AZN.L) said on Tuesday it had agreed to buy respiratory syncytial virus ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-buy-rsv-vaccine-maker-icosavax-11-bln-2023-12-12/
Quick Glance: AstraZeneca's Acquisition of US Vaccine Company in $1.1 Billion Deal
- AstraZeneca is acquiring a Seattle-based company, Icosavax, working on a potential vaccine for two common respiratory diseases.
- The US company's main vaccine targets respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), causing severe illnesses in adults over 60 and those with chronic conditions.
- In intermediate studies, the vaccine demonstrated strong immune responses against RSV and hMPV one month post-vaccination.
- It is a combination protein VLP vaccine given as a single dose.
US urges makers of infant RSV shots to meet winter demand
reuters.com/business/healthcare-pharmaceuticals/us-urges-rsv-vaccine-makers-meet-winter-demand-white-house-says-2023-12-07/
Today’s top business headlines: AstraZeneca acquisition, Apple Watch import ban, State of Hiring
fastcompany.com/91003199/todays-top-business-headlines-astrazeneca-acquisition-apple-watch-import-ban-state-of-hiring
US FDA approves AstraZeneca's breast cancer drug combination: The U.S. Food and Drug Administration on Thursday approved AstraZeneca's (AZN ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-astrazenecas-breast-cancer-drug-combination-2023-11-16/
Quick Glance: New FDA Approval for AstraZeneca's Breast Cancer Treatment
- Combination of Truqap and older drug offers new treatment option for most common type of breast cancer.
- Approval for adult patients with HR-positive/HER2-negative breast cancer and patients with altered PIK3CA, AKT1, or PTEN genes.
- Extension of progression-free survival by 7.3 months in study with altered genes.
- Common side effects include diarrhea, decreased hemoglobin, nausea, and fatigue.
CDC expedites release of 77,000 additional doses of Sanofi-AstraZeneca's RSV drug
reuters.com/business/healthcare-pharmaceuticals/cdc-releases-77000-additional-doses-sanofi-astrazenecas-rsv-drug-2023-11-16/
AstraZeneca prioritizes US for RSV drug amid surge in cases: AstraZeneca (AZN.L) on Friday said it was prioritizing the U.S. market for additional doses of its ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-prioritizes-us-rsv-drug-amid-surge-cases-2023-11-10/
Next season, you may be able to take your flu vaccine at home: The US Food and Drug Administration is reviewing an application for the nasal spray flu vaccine ...
cnn.com/2023/10/24/health/next-season-you-may-be-able-to-take-your-flu-vaccine-at-home/
A new RSV shot for infants is in short supply: A new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should ...
apnews.com/article/rsv-shot-shortage-infants-dc57b7788813cb3c00b081791b4c8ad3
Quick Glance: RSV Drug Shortage Prompts Doctor Alert
- CDC urges prioritizing new RSV drug for vulnerable infants due to limited supply.
- Experts warn of overwhelming demand for Beyfortus, first FDA-approved RSV drug.
- Sanofi reports unprecedented demand for antibody treatment despite aggressive supply plan.
- CDC advises prioritizing 100 mg doses of Beyfortus for infants under 6 months and those with underlying conditions.
FDA reviewing at-home flu vaccines: The Food and Drug Administration (FDA) will review an at-home flu vaccine as uptake for the inoculations remains low this ...
thehill.com/policy/healthcare/4274582-fda-reviewing-at-home-flu-vaccines/
Sanofi seeing 'unprecedented' demand for RSV therapy: (This Oct. 20 story has been corrected to show that the drug was co-developed by Sanofi and AstraZeneca in ...
reuters.com/business/healthcare-pharmaceuticals/sanofi-seeing-unprecedented-demand-rsv-therapy-2023-10-20/
AstraZeneca to pay $425 mln to end US lawsuits over heartburn drugs: Britain's AstraZeneca (AZN.L) said it will pay $425 million to settle lawsuits in the United ...
reuters.com/legal/astrazeneca-pay-425-mln-settle-nexium-prilosec-litigation-us-2023-10-03/
AstraZeneca seeks to calm CEO speculation after shares drop: AstraZeneca (AZN.L) appeared to play down speculation about the future of its CEO after its shares ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-shares-fall-36-7-12-week-low-2023-09-11/
Quick Glance: AstraZeneca Calms CEO Speculation Following Share Drop
- AstraZeneca downplays speculation about CEO's future
- Shares drop over 4% after report of Pascal Soriot considering leaving
- Three analysts and one shareholder confirm the report
- Times article may also have impacted share price
AstraZeneca sues US over Medicare drug price negotiation plans: AstraZeneca (AZN.L) said on Friday it has sued the U.S. government to block parts of a program ...
reuters.com/legal/astrazeneca-files-litigation-challenge-inflation-reduction-act-2023-08-25/
Quick Glance: AstraZeneca sues Inflation Reduction Act
- AstraZeneca has filed a lawsuit against the Inflation Reduction Act.
- The Inflation Reduction Act includes a program for drug price negotiation.
- AstraZeneca aims to protect access to medicines for orphan indications.
BofA reveals the global stocks that tend to outperform when the U.S. dollar rises
cnbc.com/2023/09/29/bofa-reveals-the-global-stocks-that-tend-to-outperform-when-the-us-dollar-rises.html
Paid articlePaid US FDA approves Sanofi-AstraZeneca's preventive RSV therapy for babies: The U.S. Food and Drug Administration (FDA) said on Monday it had approved Sanofi (SASY ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-sanofi-astrazenecas-preventive-rsv-therapy-babies-2023-07-17/
Quick Glance: New medication approved by FDA to protect babies and toddlers from RSV ahead of cold season
- U.S. officials have approved a new long-acting medication to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year.
- The injection was approved on Monday, July 17, 2023, for infants and children up to 2 years old.
- New research shows that another experimental Alzheimer's medication can slightly slow the inevitable worsening of patients.
- U.S. officials have approved the first over-the-counter birth control pill, a significant change that will expand access for women and teenagers.
The US is finally flexing its buying power to negotiate the prices of 10 Medicare drugs
qz.com/the-us-is-finally-flexing-its-buying-power-to-negotiate-1850786346
Paid articlePaid UK's FTSE 100 set for best week since March on hopes of Fed rate hikes ending: UK's FTSE 100 edged higher on Friday as AstraZeneca rose after HSBC took a bullish ...
reuters.com/world/uk/ftse-100-opens-flat-losses-financials-counter-healthcare-boost-2023-07-14/
UK's FTSE 100 set for best week since March on hopes of Fed rate hikes ending: UK's FTSE 100 edged higher on Friday as AstraZeneca rose after HSBC took a bullish ...
reuters.com/world/uk/ftse-100-opens-flat-losses-financials-counter-healthcare-boost-2023-07-14/
AstraZeneca turns to cows to cut U.S. carbon footprint: Drugmaker AstraZeneca (AZN.L) is switching to biogas produced from cow manure and food waste in the ...
reuters.com/sustainability/astrazeneca-turns-cows-cut-us-carbon-footprint-2023-06-13/
Chiquita Brooks-LaSure, administrator for the Centers for Medicare and Medicaid Services, and Joseph Betancourt, president of the Commonwealth Fund ... Show more
Lung cancer pill cuts risk of death by half, study finds: The drug, developed by AstraZeneca, if taken daily after surgery, dramatically reduces risk of death ...
aljazeera.com/news/2023/6/5/lung-cancer-pill-cuts-risk-of-death-by-half-study-finds
US FDA panel backs Sanofi-AstraZeneca's preventive RSV therapy: The U.S. Food and Drug Administration advisers on Thursday backed the use of Sanofi (SASY ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-backs-sanofi-astrazenecas-preventive-rsv-therapy-2023-06-08/
FDA Panel Recommends RSV Shot to Protect Infants: Advisers to the agency overwhelmingly agreed that a new treatment would help to prevent a potentially lethal ...
nytimes.com/2023/06/08/health/fda-rsv-babies-treatment.html
FDA advisors recommend AstraZeneca, Sanofi antibody to protect babies from RSV: If the Food and Drug Administration approves nirsevimab, it will be the first ...
cnbc.com/2023/06/08/fda-advisors-recommend-astrazeneca-antibody-for-infants-for-rsv.html
New Lung cancer drug cuts death risk by half, study finds - Healthwise: A pill has been shown to halve the risk of death from a certain type of lung cancer when ...
healthwise.punchng.com/new-lung-cancer-pill-cuts-death-risk-by-half-study-finds/
British Man Died of Rare Blood Syndrome Linked to AstraZeneca’s Vaccine: One expert said the blood-clotting syndrome was estimated to occur in one in 50 ...
nytimes.com/2023/04/20/science/doctor-death-astrazeneca-covid-vaccine.html
AstraZeneca’s COVID Vaccine May Have Posed a Higher Heart Risk for Young Women, Study Shows
nytimes.com/2023/03/29/health/covid-vaccine-astra-zeneca-women-heart-risk.html
U.S. FDA pulls authorization for AstraZeneca's COVID-19 treatment Evusheld: The U.S. health regulator has withdrawn emergency-use authorization for AstraZeneca's ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-withdraws-authorization-astrazenecas-evusheld-2023-01-26/
Exclusive: Drugmakers to raise prices on at least 350 drugs in U.S. in January: Drugmakers including Pfizer Inc (PFE.N), GlaxoSmithKline PLC (GSK.L) ...
reuters.com/business/healthcare-pharmaceuticals/drugmakers-raise-prices-least-350-drugs-us-january-2022-12-30/
U.S. FDA says Evusheld may not protect against Omicron subvariant XBB.1.5: The U.S. Food and Drug Administration said on Friday it does not expect AstraZeneca's ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-says-evusheld-may-not-protect-against-omicron-subvariant-xbb15-2023-01-06/
AstraZeneca lifts 2022 earnings outlook as cancer drugs boost results: AstraZeneca (AZN.L) raised its full-year earnings outlook on Thursday after strong sales ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-q3-earnings-revenue-beat-estimates-2022-11-10/
Study confirms AstraZeneca jab's higher risk of very rare clot: PARIS: AstraZeneca's COVID-19 vaccine has been linked to a 30 per cent higher risk of ...
channelnewsasia.com/world/study-confirms-astrazeneca-covid-19-vaccine-rare-blood-clot-thrombocytopenia-3027706
AstraZeneca’s anti-diabetic drug receives CDSCO approval for patients with chronic kidney disease and heart failure
financialexpress.com/healthcare/pharma-healthcare/astrazenecas-anti-diabetic-drug-receives-cdsco-approval-for-patients-with-chronic-kidney-disease-and-heart-failure/2895511/
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics